Secure Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Secure Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,566	Closed	-$849K	–	184
2021 Q1	$849K	Buy	9,566 +6,986	+271%	+$693K	0.47%	42
2020 Q4	$241K	Buy	+2,580	New	+$206K	0.14%	130

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SDH

Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Secure Asset Management's ARKG Position: Q2 2021 in Review

Secure Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 9,566 shares — an estimated $849K sold.

Secure Asset Management first reported a position in ARKG in Q4 2020 and held it in 2 quarters. The position peaked at $849K in Q1 2021. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

Secure Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
Secure Asset Management sold 9,566 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $849K.
Secure Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 2 quarters.
Secure Asset Management's ARK Genomic Revolution ETF position peaked at $849K in Q1 2021.
512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Secure Asset Management's 13F filing for Q2 2021, filed 16 Jul 2021.